Rainer Krech

1.7k total citations
38 papers, 705 citations indexed

About

Rainer Krech is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Rainer Krech has authored 38 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Rainer Krech's work include Cancer Genomics and Diagnostics (5 papers), Acute Myeloid Leukemia Research (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Rainer Krech is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Acute Myeloid Leukemia Research (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Rainer Krech collaborates with scholars based in Germany, Austria and United States. Rainer Krech's co-authors include Peter Bannasch, Heide Zerban, Ágnes Bánkfalvi, Thomas Decker, Friedrich Otterbach, Sonja Verena Bergner, Werner Boecker, J. Thiele, Reinhard von Roemeling and P. A. Reichart and has published in prestigious journals such as Cancer Research, The Journal of Pediatrics and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Rainer Krech

36 papers receiving 684 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rainer Krech Germany 16 230 163 149 142 135 38 705
Kim Ørnvold United States 14 170 0.7× 78 0.5× 90 0.6× 148 1.0× 98 0.7× 37 737
Daisy Saw China 18 208 0.9× 126 0.8× 203 1.4× 479 3.4× 151 1.1× 37 1.0k
H. Thomas Norris United States 18 169 0.7× 47 0.3× 177 1.2× 109 0.8× 220 1.6× 32 1.0k
D. Fırat Türkiye 14 115 0.5× 73 0.4× 153 1.0× 192 1.4× 130 1.0× 46 680
Takeshi Nagao Japan 16 184 0.8× 149 0.9× 98 0.7× 241 1.7× 166 1.2× 64 1.3k
Marco M. Altaras Israel 29 191 0.8× 141 0.9× 135 0.9× 313 2.2× 151 1.1× 108 2.2k
Florian Meier Germany 12 204 0.9× 70 0.4× 280 1.9× 108 0.8× 112 0.8× 42 823
Shinsuke Funakoshi Japan 18 327 1.4× 100 0.6× 107 0.7× 271 1.9× 69 0.5× 44 955
H J Gruss Germany 16 190 0.8× 96 0.6× 175 1.2× 214 1.5× 39 0.3× 26 851
Eriko Miyazaki Japan 17 256 1.1× 58 0.4× 83 0.6× 103 0.7× 180 1.3× 55 663

Countries citing papers authored by Rainer Krech

Since Specialization
Citations

This map shows the geographic impact of Rainer Krech's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rainer Krech with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rainer Krech more than expected).

Fields of papers citing papers by Rainer Krech

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rainer Krech. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rainer Krech. The network helps show where Rainer Krech may publish in the future.

Co-authorship network of co-authors of Rainer Krech

This figure shows the co-authorship network connecting the top 25 collaborators of Rainer Krech. A scholar is included among the top collaborators of Rainer Krech based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rainer Krech. Rainer Krech is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lebok, Patrick, Martina Kluth, Christina Möller‐Koop, et al.. (2021). 6q deletion is frequent but unrelated to patient prognosis in breast cancer. Breast Cancer. 29(2). 216–223.
2.
Goeschen, Klaus, et al.. (2001). Typische Erscheinungsformen des Chorionkarzinoms in der klinischen Praxis - Diagnosestellung und therapeutischer Verlauf bei vier Patientinnen. Zentralblatt für Gynäkologie. 123(7). 383–389. 1 indexed citations
3.
Hermann, Robert Michael, Rainer Krech, J. Hartlapp, et al.. (2001). Wertigkeit eines qualitativen Regressionsgradings als prognostischer Faktor für das Überleben bei präoperativ radiochemotherapierten Patienten mit fortgeschrittenen Kopf-Hals-Karzinomen. Strahlentherapie und Onkologie. 177(6). 277–282. 15 indexed citations
4.
Wagner, W., Robert Michael Hermann, J. Hartlapp, et al.. (2000). Prognostic Value of Hemoglobin Concentrations in Patients with Advanced Head and Neck Cancer Treated with Combined Radio-Chemotherapy and Surgery. Strahlentherapie und Onkologie. 176(2). 73–80. 27 indexed citations
5.
Bánkfalvi, Ágnes, et al.. (1999). Standardized In Situ AgNOR Analysis in Breast Pathology: Diagnostic and Cell Kinetic Implications. Pathology - Research and Practice. 195(4). 219–229. 10 indexed citations
6.
Müller, Thomas, Hansjörg Schäfer, Burkhard Rodeck, et al.. (1999). Familial clustering of infantile cirrhosis in Northern Germany: A clue to the etiology of idiopathic copper toxicosis. The Journal of Pediatrics. 135(2). 189–196. 22 indexed citations
7.
8.
Bánkfalvi, Ágnes, et al.. (1998). Gains and losses of CD44 expression during breast carcinogenesis and tumour progression. Histopathology. 33(2). 107–116. 57 indexed citations
9.
Krech, Rainer, et al.. (1998). Adulte Riesenzellhepatitis mit tödlichem Verlauf. Der Pathologe. 19(3). 221–225. 3 indexed citations
10.
Krech, Rainer, et al.. (1998). Primäres Plattenepithelkarzinom der weiblichen Brustdrüse. Der Pathologe. 19(5). 373–378. 2 indexed citations
11.
Edel, G., et al.. (1997). Expression of Biglycan, Decorin and Proteoglycan-100/CSF-1 in Normal and Fibrotic Human Liver. Pathology - Research and Practice. 193(11-12). 747–751. 32 indexed citations
12.
Krech, Rainer, et al.. (1995). Inflammatorischer Pseudotumor der Leber Morphologische und zytophotometrische Untersuchungen sowie Differentialdiagnose. Der Pathologe. 16(6). 415–420. 10 indexed citations
13.
Baretton, Gustavo, Beatrice G. Kuhlmann, Rainer Krech, & U. Löhrs. (1992). Intratumoural heterogeneity of nuclear DNA-content and proliferation in clear cell type carcinomas of the kidney. Virchows Archiv B Cell Pathology Including Molecular Pathology. 61(1). 57–63. 17 indexed citations
14.
Krech, Rainer, et al.. (1991). Ovargravidität nach Gametentransfer (GIFT) Ein Fallbericht. Geburtshilfe und Frauenheilkunde. 51(11). 945–947. 2 indexed citations
15.
Kreft, Burkhard, Cor de Wit, Rainer Krech, et al.. (1990). Experimental studies on nephrotoxicity and pharmacokinetics of LY 146032 (daptomycin) in rats. Journal of Antimicrobial Chemotherapy. 25(4). 635–643. 11 indexed citations
16.
Krech, Rainer, V. Loy, K.‐P. Dieckmann, Johannes Gerdes, & H. Stein. (1989). Leiomyosarcoma of the Kidney. Immunohistological and Ultrastructural Findings with Special Emphasis on the Growth Fraction. British Journal of Urology. 63(2). 132–134. 5 indexed citations
17.
Krech, Rainer, et al.. (1987). [Immunohistologic characterization of chordomas].. PubMed. 8(4). 207–12. 5 indexed citations
18.
Thiele, J., et al.. (1987). The use of the anti-factor VIII method on trephine biopsies of the bone marrow for the identification of immature and atypical megakaryocytes in myeloproliferative diseases and allied disorders. Virchows Archiv B Cell Pathology Including Molecular Pathology. 54(1). 89–97. 11 indexed citations
19.
Krech, Rainer, Heide Zerban, & Peter Bannasch. (1981). Mitochondrial anomalies in renal oncocytes induced in rat by N-nitrosomorpholine.. PubMed. 25(2). 331–9. 26 indexed citations
20.
Krech, Rainer & P Bannasch. (1978). [Mitochondrial abnormalities in carcinogen-induced oncocytes of the rat kidney].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 62. 495–495. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kim Ørnvold Breakdown of academic impact, for papers by Daisy Saw Breakdown of academic impact, for papers by H. Thomas Norris Breakdown of academic impact, for papers by D. Fırat Breakdown of academic impact, for papers by Takeshi Nagao Breakdown of academic impact, for papers by Marco M. Altaras Breakdown of academic impact, for papers by Florian Meier Breakdown of academic impact, for papers by Shinsuke Funakoshi Breakdown of academic impact, for papers by H J Gruss Breakdown of academic impact, for papers by Eriko Miyazaki
Rankless by CCL
2026